HIST1H2BK predicts neoadjuvant-chemotherapy response and mediates 5-fluorouracil resistance of gastric cancer cells

Background: Neoadjuvant chemotherapy (NACT) is routinely used to treat patients with advanced gastric cancer (AGC). However, the identification of reliable markers to determine which AGC patients would benefit from NACT remains challenging. Methods: A systematic screening of plasma proteins between...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Zijian Chen, Xiaocheng Tang, Weiyao Li, Tuoyang Li, Jintuan Huang, Yingming Jiang, Jun Qiu, Zhenze Huang, Rongchang Tan, Xiang Ji, Li Lv, Zuli Yang, Hao Chen
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	Elsevier 2024-08-01
Rangatū:	Translational Oncology
Ngā marau:	HIST1H2BK Neoadjuvant Chemotherapy Gastric Cancer Plasma 5-Fluorouracil
Urunga tuihono:	http://www.sciencedirect.com/science/article/pii/S193652332400144X
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!